Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ASENAPINE MALEATE, with a corresponding US DMF Number 26104.
Remarkably, this DMF maintains an Active status since its submission on May 30, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 20, 2024, and payment made on December 13, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II